澳门威斯人游戏(中国)官方网站NO.1-One

The workshop of Truking SUT(Changsha) Co., Ltd., a holding subsidiary of Truking Technology, located inNingxiang, Hunan Province, was officially put into operation on May 12. This isanother important progress in the layout of biopharmaceutical front-end processtechnology and equipment since Truking Technology established SUT in August2021. The establishment and the construction of SUT Changsha factory is animportant step in the expansion of the product chain of Truking, and is alsoone of the important achievements of the investment promotion of the localgovernment and the development of the local biopharmaceutical industry chain.Mr. Tang, and other Company executives and customer representatives witnessedthe ceremony and visited the factory.

Truking introduced high-end talents inthe field of biotechnology and established a holding subsidiary, Truking SUTBiotechnology (Changsha) Co., Ltd. in August 2021. SUT focuses on the R&Dand production of single-use products. It already has single-use bioreactors,liquid dispensing bags, liquid storage bags and their membrane materials.Single-use technology has been used in the medical and biopharmaceuticalindustries for more than 30 years, from single-use infusion bags to single-usebioreactors, from widely used laboratory pipette tips to single-use fillingneedles. With the development of life science and the advancement of materialtechnology, the application of single-use technology is changing with eachpassing day.

The wide application of single-usetechnology in the field of modern biopharmaceuticals has accelerated theprocess of new drugs from R&D, pilot testing to commercial production,while effectively reducing the input cost and cycle of production lineconstruction. Especially in the global outbreak of the COVID-19, the vaccinemanufacturers have generally adopted a single-use process technology, so thatthe vaccine can be produced quickly, safely, and in batches in a shorter periodof time, and put into the market, which plays a crucial role in effectivelyblocking the spread of the pandemic. The core team members of SUT are fromworld-renowned biopharmaceutical companies or single-use product manufacturers,and they all have long-term and rich work and research experience.

Visited Truking SUT Changsha Factory

Truking SUT Workshop in Changsha hasnearly 6,000 square meters, covering C-level purification workshops andfacilities such as integrity testing lab, microbiological testing lab,sterility testing lab, and physical & chemical testing lab to ensure theproduction of high standard single-use systems. Truking SUT has also set up asubsidiary company and production base in Shanghai to better connect withcutting-edge biopharmaceutical resources. Changsha & Shanghai productionbases will greatly promote our delivery capacity, further promote thedevelopment in bioengineering technology and equipment of Truking.

Based onpharmaceutical equipment, supplemented by informatization, intelligentmanufacturing and verification, expanding to related process consumables,packaging materials, auxiliary materials, and process engineering, graduallytransitioning from equipment solutions company to overall technical solutionscompany is the development strategy of Truking, the layout and expansion of thebioengineering product line is an important part of this.

Wang Yingqun, GMof Guangzhou BeiGene Biopharmaceutical Co., Ltd., delivered a speech

Through the combination of online andoffline methods, many customers of Truking have witnessed the commissioning ofthe SUT Changsha factory and visited the factory. Mr. Wang Yingqun, GeneralManager of Guangzhou BeiGene Biopharmaceutical Co., Ltd., said that Truking hashigh-level technology, high-quality products, high-efficiency manufacturing, andprofessional fast service and response, which have provided extremely valuablehelp to enterprises. The continuous development of the biological engineeringlayout of Truking will bring more new value to the field of biopharmaceuticals." Hope to make more contributions to the cause of human healthtogether"

Tang Yue, Chairman and President of Truking, delivereda speech

Truking was founded 22 years ago,"and 12 years ago, when we were preparing to be listed, we proposed the enterprise development strategy of 'building one vertical chain, one horizontal chain and one platform'." said Mr. Tang Yue, Chairman and President ofTruking, "One vertical chain" covers the entire product chain ofsterile drug production equipment, "One horizontal chain" covers theentire product chain of major pharmaceutical dosage forms and equipment,"One platform" is to build up the capabilities of verification,testing, design, engineering services and other aspects to provide customerswith overall technical solutions. The second major strategy of Truking is going global. "In 2017, we acquired Romaco Group, a world-renownedpharmaceutical equipment company, making a great process in going global."

The mission of Truking is to"Equip global pharmaceutical manufacturing industry with intelligentwings", Mr. Tang said, "In such a dimension to pushinternationalization to a new height. The company continues to develop, but themain channel has never changed. Moving forward along the professional fields ofpharmaceutical equipment and technology, the same is true for the operation ofSUT Changsha factory today. While expanding our business areas, we have alwaysadhered to the professional path. The commissioning of SUT Changsha factory isa new page in the development of Truking bioengineering product line, whichwill make the image of Truking not only stay at the level of pharmaceuticalequipment enterprise, but develop from an equipment solution company to atechnology solution company."